Hospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort

    Viruses, Vol. 16, Núm. 3

2018

  1. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”

    Atherosclerosis, Vol. 275, pp. 265-272

2012

  1. Documento Abordaje de la dislipidemia. Sociedad Española de Arteriosclerosis (parte II)

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 1, pp. 40-52

  2. Documento Abordaje de la dislipidemia. Sociedad Española de Arteriosclerosis (parte III)

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 2, pp. 102-107

2011

  1. Documento Abordaje de la dislipidemia. Sociedad Española, de Arteriosclerosis (Parte I)

    Clinica e Investigacion en Arteriosclerosis, Vol. 23, Núm. 6, pp. 278-288

2008

  1. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: A 12-week, multicenter, randomized, open-label, parallel-group study

    Clinical Therapeutics, Vol. 30, Núm. 1, pp. 84-97

2007

  1. Cardiovascular risk assessment

    Medicina Clinica, Vol. 129, Núm. 14, pp. 534-541

  2. Diagnóstico y tratamiento del riesgo cardiometabólico

    Medicina Clinica